CBP audits coming? Learn 5 key steps to prepare for 2026, from internal reviews to using compliance software like TradeWin, and avoid penalties.
Editorial Team
·
Biotech funding for gene-editing platforms now demands clear clinical progress and market paths. Learn what founders need for Series B and C capital.
·
Pharma faces high costs. See 5 ways to improve drug development ROI, like using AI to cut early-phase costs by up to 30%, speeding new treatments.
·
Can economic policy fix global obesity? Learn why market forces, not just personal choice, drive rising rates; over half obese by 2035.
·
Global conflict cost $1.5T in 2023. See how peace could drive a 20-30% FDI surge, boost trade, and create jobs by 2027.
·
·
6 min read
H-1B visa compliance is now a C-suite priority. Learn why increased USCIS scrutiny and DOL data analytics demand precision from firms by 2026.
·
·
8 min read
Why is Ukraine investment down 65% since 2021? Understand shifting global investor sentiment, energy sector interest, and reconstruction challenges.
·
·
6 min read
Childhood obesity solutions drew $2.1B in 2025 investments. See how health tech and food innovation are tackling this public health challenge.
·
·
8 min read
Consumer gene editing arrives by 2026. Understand the ethics, safety, and lack of transparent labeling for new products. Market to hit $30B.
·
·
5 min read
Investing in CTV ad tech in 2026? Understand how to evaluate media measurement, cross-screen deduplication, and data clean rooms for strong ROI.
·
·
5 min read
